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Comprehensive in vitro and in vivo 
studies of novel melt-derived Nb-
substituted 45S5 bioglass reveal its 
enhanced bioactive properties for 
bone healing
Lucas Souza  1, João Henrique Lopes  2, Davi Encarnação2, Italo Odone Mazali  3, 
Richard Alan Martin4, José Angelo Camilli1 & Celso Aparecido Bertran2
The present work presents and discusses the results of a comprehensive study on the bioactive 
properties of Nb-substituted silicate glass derived from 45S5 bioglass. In vitro and in vivo experiments 
were performed. We undertook three different types of in vitro analyses: (i) investigation of the kinetics 
of chemical reactivity and the bioactivity of Nb-substituted glass in simulated body fluid (SBF) by 31P 
MASNMR spectroscopy, (ii) determination of ionic leaching profiles in buffered solution by inductively 
coupled plasma optical emission spectrometry (ICP-OES), and (iii) assessment of the compatibility and 
osteogenic differentiation of human embryonic stem cells (hESCs) treated with dissolution products 
of different compositions of Nb-substituted glass. The results revealed that Nb-substituted glass is not 
toxic to hESCs. Moreover, adding up to 1.3 mol% of Nb2O5 to 45S5 bioglass significantly enhanced its 
osteogenic capacity. For the in vivo experiments, trial glass rods were implanted into circular defects in 
rat tibia in order to evaluate their biocompatibility and bioactivity. Results showed all Nb-containing 
glass was biocompatible and that the addition of 1.3 mol% of Nb2O5, replacing phosphorous, increases 
the osteostimulation of bioglass. Therefore, these results support the assertion that Nb-substituted 
glass is suitable for biomedical applications.
Fractures, bone tumours, periodontal diseases, and degenerative cartilage disorders disrupt daily activities of 
people. Therapeutic approaches to these pathologic conditions prompted the development of materials that could 
replace bone and joint tissues1–3. Many materials were produced based on metals, such as aluminium, zirconia 
and titanium, and were used in orthopaedics for manufacturing prosthesis, plates, nails, screws, and other such 
components. However, as these materials in general have a lifespan of around 10–20 years and human life expec-
tancy has increased, these implants frequently deteriorate prior the patient’s death4–6.
At the beginning of the 1970s, the researcher Larry. L. Hench and his colleagues developed the first bioactive 
material, the 45S5 bioglass (Bioglass®). This biomaterial not only induced no inflammatory response in the body, 
but also formed strong bonds with bone and soft tissues, optimizing stability of the implant and extending its 
durability6–8. This material is a bioactive glass belonging to the system SiO2-CaO-Na2O-P2O5 (46.1 mol% SiO2, 
26.9 mol% CaO, 24.4 mol% Na2O, and 2.6 mol% P2O5)9. The strong interface between biomaterial and tissue is 
established through chemical reactions that occur on the surface of the bioglass, concomitant with biological 
events leading to the formation of a nanocrystalline calcium phosphate hybrid composite permeated by biological 
molecules7,8.
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Several articles have been published, reviewing the literature discussing the effect of 45S5 bioglass composi-
tion on bioactivity, angiogenesis, osteostimulation, osteoconduction, and other important properties for bone 
regeneration10–14. As the chemical composition of glass dictates its effects on living tissues, many other variations 
of the original Bioglass® have been manufactured and investigated for use as biomaterial; some of them showed 
high bioactivity, for example 58 S, S53P4, and 70S30C2,15–19.
Furthermore, several types of transition metal-doped soda lime silica glass have been prepared, and their 
bioactivity has been evaluated for biomedical applications20,21. Among the various vitreous compositions investi-
gated, glass containing niobium oxide have received special attention, since the presence of niobium species has 
been associated with improvements in bioactive and mechanical properties22–26. Moreover, recent works have 
reported the ability of niobium ions to enhance differentiation and mineralization of osteogenic cells in vitro24,25. 
Metallic niobium has been used in titanium alloys for endosseous implants, aiming to increase the biocompati-
bility and corrosion resistance, with superior fatigue resistance27. Similar behaviour of phosphate bioactive glass 
was observed on adding Nb2O523,26. It is noteworthy, however, that the Nb2O5 is an effective nucleating agent and 
generally leads to the development of glass-ceramic in silica-poor compositions (inverted glass), such as 45S528.
In our previous study, the structures of two series of bioglass (derived from 45S5 Bioglass® composition) 
with varying niobium oxide contents were exhaustively investigated by multinuclear 29Si, 31P, and 23Na solid-state 
MAS NMR and Raman spectroscopy, and some physical properties of the glass were also studied29. The struc-
tural investigation of bioglass resulting from the substitution of P2O5 by Nb2O5 revealed that Nb2O5 participates 
in the silicate network by breaking the Si-O-Si bonds to form structures, such as -Si-O-Nb-O-Si- chains. These 
alterations significantly changed the glass dissolution rate and magnitude, which is of interest for understanding 
its higher bioactivity29,30.
Even though Nb-substituted silicate glass appears to possess interesting bioactive properties, its effect over 
pluripotent cells and bone regeneration has not been investigated till date. In view of this, the objective of this 
study was to evaluate the in vitro and in vivo effects of different compositions of Nb-substituted bioglass on 
properties, namely, cytotoxicity, osteoinduction, osteoconduction, and osteostimulation, that are essential for 
osteointegration of medical materials for bone replacement. The in vitro approach consisted of treating human 
embryonic stem cells (hESCs) with the dissolution products from the glass and verifying cell viability and osteo-
genic differentiation. For the in vivo assay, glass rods were implanted into circular defects in rat tibia and bone for-
mation was quantified. In addition, the leaching profile of Si, Ca, Na, P, and Nb species from the bioglass, and the 
kinetics of structural transformations of different compositions of Nb-substituted silicate glass were investigated.
Results and Discussion
Dissolution studies. The leaching rate of Na, Ca, Si, and P ions from bioglass in the earliest stages of the bio-
reactivity is of utmost importance since the results of the leaching processes will control the subsequent biomin-
eralization. To examine leaching rates, two promising compositions of Nb2O5-containing bioactive glass were 
studied. The 45S5 bioglass composition is also presented for the purpose of comparison. The nomenclature and 
chemical composition of all samples studied in this work are shown in Table 1.
The effect of Nb2O5-content on the glass solubility was studied by time-dependence of species release from 
bioglass particles dispersed in 50.69 mM HEPES buffered solution (pH = 7.4). The leaching curves for Na, Ca, Si, 
P (Fig. 1) and Nb (Fig. 2) species were determined by using inductively coupled plasma optical emission spec-
trometry (ICP-OES).
We found that the initial elemental concentrations of sodium, calcium, silicon, and phosphorus, up to about 
120 min for all compositions, are a linear function of the square root of time, which indicates a diffusion-controlled 
process (Supplementary Information – Fig. SI1a–d)8. The shape of the curves is consistent with Hench’s mecha-
nism, which describes all events on bioglass surface in contact with body fluid in five steps: (i) rapid exchange of 
Na+/Ca2+ from glass network with H3O+ from solution, (ii) loss of soluble silica/ formation of silanol groups at 
the glass solution interface, (iii) condensation and repolymerization of a SiO2-rich layer, (iv) growth of the amor-
phous CaO-P2O5-rich film by incorporation of soluble calcium and phosphates from solution, (v) crystallization 
of the amorphous CaO-P2O5 film by incorporation of OH− and CO32− anions from solution4,7,31.
The leaching profiles of network modifier ions, Na+ and Ca+, for BG45S5 and Nb2O5-substituted bioglass 
showed an abrupt increase, reaching a maximum concentration value for these species at around 2 hours and 
remaining constant for longer times (Fig. 1a,b). The release curves showed that the amount and rate at which Na 
and Ca ions are leached from the glass networks were similar to each other, in particular, within the first hours 
after dipping. This result is of extreme importance because it shows that the replacement of P2O5 by the Nb2O5 in 
the 45S5 composition did not alter the onset of the cascade of events, which includes ion exchange between Na+ 
and Ca2+ ions and H3O+, as described by the Hench mechanism for biomineralization7,31,32. In addition, recogniz-
ing that sodium niobate and/or calcium niobate are highly water insoluble species close to the neutral pH, these 
results corroborate with those previously reported on structural data for these glassy compositions29, suggesting 
Glass
SiO2 CaO Na2O P2O5 Nb2O5
BG45S5 46,1 26,9 24,4 2,6 —
BGPN2.6 46,1 26,9 24,4 — 2,6
BGPN1.3 46,1 26,9 24,4 1,3 1,3
Table 1. Glass compositions of BG45S5 and Nb-substituted 45S5 bioglass.
www.nature.com/scientificreports/
3SCIentIFIC REPORTs |  (2018) 8:12808  | DOI:10.1038/s41598-018-31114-0
that niobium (NbO6) would be behaving as a network former by establishing chemical bonds with silicon tetra-
hedral (Si-O-Nb-O-Si) in the glass backbone (chain of alternating Si and O atoms).
Conversely, the leaching curves for the species of silicon and phosphorus showed peculiar behaviours for each 
bioglass composition (Fig. 1c,d). The amounts of soluble silicon species determined after the first hour of immer-
sion were similar, except for the BGPN2.6 sample, which exhibited a reduced concentration of silicon. This result 
indicates the presence of Si-O-Nb bonds, where the NbO6 octahedra replaces part of the SiO2 tetrahedra in the 
glass network. Evidently, an increase in niobium content in the composition must result in a greater number of 
Nb-O-Si bonds, so that such structures may act as traps for the silicon species in the glass matrix, preventing and 
Figure 1. ICP data: ion release vs. time in 50.69 mM HEPES solution at pH 7.40 for BG45S5 and Nb-
substituted bioactive glass. The data displayed in (a–d) are related to leached Na, Ca, Si, and P species from glass 
derived from substitution of P2O5 for Nb2O5.
Figure 2. ICP data: Nb ion release vs. time in 50.69 mM HEPES solution at pH 7.40 for BG45S5 and Nb-
substituted bioactive glass. The amounts of niobium determined by ICP-OES is consistent with the niobium 
content in each sample, i.e. BGPN2.6 exhibits a higher peak of niobium concentration compared to the 
BGPN1.3 bioglass. As expected, no niobium was detected for BG45S5.
www.nature.com/scientificreports/
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delaying their leaching. The release profile of phosphorus suggests a maximum concentration (approximately the 
solubility limit), from which there is a dramatic reduction, possibly associated with the removal of some of the 
soluble phosphate species to form the calcium phosphate layer on the bioglass surface (Fig. 1d). Although the rate 
at which species of phosphorus are released into solution is similar to BG45S5 and BGPN1.3 samples, the removal 
of phosphorus from solution is slower for the BGPN1.3, which can be attributed to its lower P2O5 concentration 
(phosphorus concentration was not high enough to reach the limit solubility of calcium phosphate). As expected, 
no appreciable amount of phosphate species was observed for BGPN2.6.
The leaching curves for the species of niobium exhibit similar profiles to those observed for phosphorus spe-
cies (Fig. 2).
At early soaking times, it is possible to observe an abrupt increase in the niobium concentration in the 
medium, reaching a maximum value, followed by a dramatic reduction of concentration value. This initial burst 
can be credited for the leaching of niobium species near surface and/or release of isolated NbO6 units isolated nio-
bium octahedral in the vitreous matrix, which are more labile since their release does not require extra energy to 
break bonds. The maximum niobium species concentration determined for samples BGPN1.3 and BGPN2.6 was 
0.4 ppm after 30 s and 0.9 ppm after 1 minute, respectively. The drastic decrease in niobium content observed for 
samples BGPN1.3 and BGPN2.6 is closely related to the very low solubility of niobium species at pH 7.4 in aque-
ous medium. The presence of a second peak of Nb concentration was observed for the BGPN1.3 and BGPN2.6 
bioglass of 0.4 ppm after 5 minutes and 0.5 ppm after 120 minutes, respectively. This second event is directly 
related to the leaching of isolated niobium species in the bulk and/or Nb species that were more firmly trapped 
in the vitreous network. Again, the abrupt decrease in niobium concentration is due to the fact that the product 
solubility is small for niobium species. In fact, the concentration of niobium after each release peak tends to go to 
zero, confirming that the residence time of the Nb species in the solution body is short. Consequently, almost all 
niobium, if not all, may be retained in aggregates in the solution (removed during the filtration step) or in silica 
gel formed at the bioglass/solution interface.
Generally, it is common to use chelating agents such as citrates and oxalates to increase the solubility of nio-
bium species33,34. It is noteworthy that all the studies of leaching presented in this report were carried out using 
a medium containing HEPES, which is an often-used agent in studies, among several other reasons because 
it does not chelate with metals. Obata et al.25 investigated a glass series belonging to 60CaO-30P2O5-(10−x)
Na2O-xNb2O5 - system (mol%, x = 0–10) and quantified the content of niobium in the leachate by ICP-OES after 
a few hours of immersion. However, in this study, the dissolution of the glass was carried out in a complex culture 
medium (minimal medium culture + bovine serum) containing various chelating ligands, which may explain the 
presence of niobium in the solution. It is also worth noting that these phosphate glasses studied by Obata and 
co-workers can dissolve completely in aqueous solution giving ionic species, which may form precipitates upon 
reaching the maximum solubility (solubility product constant - Ksp). Moreover, another important point deserv-
ing attention in the work of Obata is that the culture medium has not apparently been filtered, consequently, the 
undissolved vitreous particles and the possibly formed ionic-molecular agglomerates, both containing niobium, 
remain in the medium. Hence, not only the niobium species chelated in the medium, but also those present in the 
glass particles or aggregates are released into the solution during the oxidation step of the organic material (com-
monly under acidic conditions) required for ICP-OES analysis were quantified25. Thus, the low solubility of the 
species of niobium in solution together with the filtration step using membranes of 0.22 μm, and the absence of 
chelating agents in the present study suggests that the Si-O-Nb bond undergoes hydrolysis, but only small amount 
of niobium goes into the solution, while the leached niobium tends to form complex structures (niobium-silica 
gel layer), which is retained on the glass surface.
Apatite layer formation ability by 31P MAS NMR spectroscopy. The development of an apatite layer 
on the bioglass surface in the physiological environment (even under simulated conditions) is a common feature 
among all the bioactive vitreous compositions described in the literature7,8,16,35. Therefore, the time required for 
this layer to be established has been an initial parameter for assessing and ranking the different vitreous com-
positions in the bioactivity domain, since apatite is a cell-friendly environment8,18. In contrast to other analysis 
methods, MAS NMR spectroscopy is a powerful, univocal and sensitive tool for studying changes in the chemical 
environment of phosphorus, capable of identifying subtle changes in local structural arrangement of phosphorus 
even for early soaking times. The partial dissolution and apatite formation on the bioglass surface in simulated 
body fluid (SBF) has been verified by 31P MAS NMR (Fig. 3(a–d)).
The 31P MAS NMR spectrum of BG45S5 consists of one broad resonance with linewidth of 7.9 ppm and 
peak maximum at 9.0 ppm assigned to isolated orthophosphate units, which coordinate modifier cations (Na+ 
and Ca2+), subtracting them from the silicate network29,30. The 31P resonance spectra for the glass compositions 
containing Nb2O5 illustrate a similar spectrum to BG45S5 with one broad resonance and asymmetric peak with 
a chemical shift ranging from 18 to −3 ppm with an approximate linewidth of 8 ppm.
31P MAS NMR peak positions and full width half maximums (FWHM) for BG45S5 and Nb-substituted glass, 
unreacted and after 3, 12, and 24 hours of immersion in SBF are listed Table 2. 31P MAS NMR spectrum of com-
mercial hydroxyapatite was added as a reference for the phase of calcium phosphate formed.
In general, 31P MAS NMR spectra for all glass exhibit the same trends, which can be summarised by the chem-
ical shift to lower frequencies and a decrease in FWHM values. Such spectral changes are intimately related to par-
tial degradation of glass and precipitation of amorphous calcium phosphate and its progressive crystallization30.
31P MAS NMR spectra for BG45S5 (Fig. 3a) and BGPN1.3 (Fig. 3b) after 3 hours of incubation in SBF showed 
a main peak at ~4 ppm with slight asymmetry on the left-hand side of the peak owing to the residual glass frac-
tion. This subtle spectral feature was not observed for BGPN2.6 (Fig. 3c), which exhibited a single and symmet-
rical peak at 3.6 ppm, confirming that the presence of P2O5 in the glass bulk is not mandatory for precipitation 
of calcium phosphate layer. Although subtle, the changes observed in the spectra in the range of 3–24 hours are 
www.nature.com/scientificreports/
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related mainly to the gradual increase in the crystallinity of calcium phosphate (increase of long-range order). 
The 31P MAS NMR spectra after 24 hours in SBF for all the glass compositions show chemical shifts and band-
widths similar to those observed for commercial hydroxyapatite (top spectrum in Fig. 3c). These results indicate 
that glass containing niobium leads to the formation of a calcium phosphate with a higher degree of crystallin-
ity compared to BG45S5, with similar soaking time in SBF. In fact, it has been reported that Nb-OH groups in 
the amorphous phase of sol-gel-derived niobium oxide gels are very effective for apatite nucleation, which is a 
friendly environment for cells36.
Figure 3. 31P MAS-NMR spectra for the different glass compositions, recorded at a magnetic field strength of 
9.4 T and a spinning speed of 10 kHz: (a) BG45S5, (b) BGPN1.3, and (c) BGPN2.6. The chemical environmental 
for 31P shifts progressively evolves to lower values of δ, reaching a peak position similar to the 31P spectrum 
observed in the hydroxyapatite control. The absence of phosphorus in BGPN2.6 did not prevent the calcium 
phosphate layer formation on its surface.
www.nature.com/scientificreports/
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Biocompatibility assessment. The first step when developing a new biomaterial to be used for tissue 
replacement is to ensure that it cannot represent a risk when implanted into the body. Therefore, we carried out 
in vitro and in vivo experiments to test the biocompatibility of Nb-containing glass. In the in vitro approach we 
treated human embryonic stem cells (hESCs), CCTL12, with the dissolution products of Nb-containing glass 
(BGPN1.3 and BGPN2.6) and the control glass (BG45S5) for 14 days and performed a resazurin assay. This assay 
revealed that none of the glass compositions were cytotoxic (Fig. 4).
Both, BG45S5 and BGPN1.3 glass showed similar fluorescence relative to that of the control group (cHES 
medium) after 14 days of treatment (P > 0.05). This result corroborates with those from some other reports22,25,37 
that have studied the cytocompatibility of bioactive glass containing niobium; these studies concluded that the 
addition of this metal does not impair the compatibility of the biomaterial. One of these reports showed that when 
osteoblast-like cells are in direct contact with the surface of calcium phosphate invert glasses (PIGs) containing 
Nb2O5 they attach and spread after 6 hours on all different concentrations of soluble niobium species25. The same 
authors performed experiments with dissolution products of niobium-doped PIGs and revealed that they are not 
harmful for osteoblast-like cells (MC3T3-E1), and instead they stimulated some positive biological responses25.
Similar results were found by another study using a different cell line and a different formulation24. In this 
study, human mesenchymal stem cells (hMSCs) were cultured on niobium-doped fluorapatite glass-ceramics, 
and the results showed that after 3 hours, the hMSCs attached on niobium glass as well as they did on the control 
surface; the report also shows the scanning electron microscopy (SEM) micrographs of cells attached to the glass 
surface after 2–4 days24.
Testing cytocompatibility is not enough to ensure the safety of implants. Inorganic material may intoxicate 
some high-metabolic-rate organs that participate in the metabolism and excretion of the material, for example the 
liver and kidneys, which may lead to morphological alterations in these organs. Because of that, we calculated the 
relative weights of the livers and kidneys of rats that had undergone implantation of glass rods at circular defects 
in their tibia, and compared the mean values with a control group of rats. We observed no difference between the 
groups neither after 14 nor 28 post-operative days, proving that no alterations in these organs were caused by the 
presence of the inorganic implants (Table 3).
Average values of 6 animals. represented by mean ± SEM. Considering p < 0.05 no significant difference was 
detected. One-way ANOVA followed by Student Newman-Keuls test. Sham = no bone defect was created.
Figure 4. Relative fluorescence of hESCs stained with 5 μM of resazurin after 14 days of treatment with 
different culture media. There was no significant difference between the groups, which shows that none of the 
media were cytotoxic for this cell line. This study was carried out only for the BG45S5 and BGPN1.3 samples. 
cHES: conditioned human embryonic stem cells medium.
Glass
31P MAS NMR
Immersion time in SBF (hours)
0 3 12 24
Peak 
(ppm)
FWHM 
(ppm)
Peak 
(ppm)
FWHM 
(ppm)
Peak 
(ppm)
FWHM 
(ppm)
Peak 
(ppm)
FWHM 
(ppm)
BG45S5 11.9 7.9 4.0 6.2 4.3 6.6 4.0 6.1
BGPN1.3 11.6 7.9 3.9 6.0 3.9 5.9 4.0 6.0
BGPN2.6 — — 3.5 5.9 3.8 5.9 3.7 5.8
Reference
Hydroxyapatite 3.4 2.7 — — — — — —
Table 2. 31P MAS NMR peak positions and full width half maxima (FWHM) for BG45S5, Nb-substituted 45S5 
bioglass and commercial hydroxyapatite.
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Taken together, these results suggest that regardless of the biological model and material formulation used, 
Nb-substituted bioglass is biocompatible, and such bioglass have proved to be excellent candidates for biomedical 
applications.
Osteogenic potential of Nb-containing bioglass. Several studies have shown that by transplanting 
adequate numbers of competent osteoprogenitor cells on biomaterial scaffolds, cell-based bone tissue engineering 
strategies may promote functional reconstruction of skeletal defects38–40. We chose to work with human embry-
onic stem cells (hESCs) because we believe these cells show some important advantages compared to other more 
commonly used multipotent cell types like mesenchymal stem cells (MSCs). We understand that MSCs may rep-
resent a reliable source of multipotent stem cells for bone cell transplantation. However, the fact that the numbers 
of adult MSCs are limited, and decline with age41, and because they are present at different stages of differentiation 
at the time of harvest42, their use is not without problems. Human ESCs, on the other hand, possess unlimited 
growth and differentiation potential, accessibility, and do not require a donor site43, facilitating the acquisition of 
a large amount of cells to be used with biomaterial scaffolds for bone regeneration.
The capacity of niobium to stimulate osteogenic differentiation of hESCs was tested by the analysis of matrix 
mineralization, carried out after 21 days of treatment. This assay revealed the formation of large calcified nodules 
on the cells treated with BGPN1.3, which suggests cells differentiated into osteoblasts that formed a mineralized 
bone matrix. These nodules were larger than those observed in the cells treated with BG45S5 (Fig. 5).
The products leached from bioactive glass seem to stimulate stem cells to proliferate and differentiate to osteo-
blasts by activating different intracellular pathways4,6,44. Lopes et al. observed that the incorporation of up to 1.3% 
of Nb2O5 by replacing the P2O5 in a SiO2-Na2O-CaO-P2O5-Nb2O5 system imposed significant structural changes 
on the glass, altering its solubility and the rate and magnitude of the Na, Ca, Si and P species leaching from the 
glass network, compared to niobium-free bioglass29.
Although a receptor for Si has not been identified yet, this ion has been shown to be one of the main com-
ponents of bioglass that is responsible for osteogenic stimulation4,45,46. As a component of silicic acid [Si(OH)4], 
silicon has been shown to stimulate osteoblasts to produce collagen I, which is the main component of the extra-
cellular bone matrix44. On the other hand, the receptors and intracellular pathways activated by Ca+2 in osteo-
blasts as well as its indirect roles in the bone formation process are very well described44,47.
It is well known that calcium possesses both structural and signalling roles in regulating bone homeosta-
sis44,48–50. Structurally, hypercalcemia is required to produce mineralized bone as it is combined with PO4−3, pre-
cipitating as calcium phosphate, which constitutes the inorganic phase of the bone matrix. Furthermore, Ca has 
an important role in regulating bone homeostasis by signalling pathways in bone-forming osteoblasts44,48,50,51. It 
has been reported that this ionic signalling enhances proliferation of stem and mature bone cells through binding 
to a G-protein, coupled to an extracellular calcium sensing receptor, in a process dependent on nitric oxide (NO) 
production. Downstream in this signalling, the P13K/Akt pathway is activated, ensuring the surveillance of the 
osteoblasts44.
Niobium species seem to have a direct effect on cells. This fact was demonstrated by Obata et al. by treating 
mouse osteoblast-like cells (MC3T3-E1 cell) with media containing different concentrations of niobium ions 
(between 1 ×  10−8 to 1 ×  10−5 M)25. Their results showed that, independent of the concentration, niobium did 
not compromise cell proliferation. Besides this observation, they noted that the ions stimulated a significantly 
higher alkaline phosphatase activity (APA) in a dose-dependent manner, indicating cell differentiation after 14 
days, even in a medium devoid of an osteogenic supplement. When osteogenic media was conditioned with the 
same ion concentrations, a significant dose-dependent increase was observed in calcium deposition compared to 
that in the osteogenic medium without niobium ions, suggesting that the niobium ions stimulated greater calcium 
deposition, which is an indicator of cell maturation. Although we have not studied specific intracellular pathways, 
we suggest that the greater osteogenic differentiation stimulated by Nb-substituted bioglass observed in our study 
may have been caused by the presence of niobium species, since the amount of the other bioactive ionic species 
(based on Si, Ca, Na, P) were similar between the groups. This suggestion corroborates with the results of the 
aforementioned study25.
It is worth mentioning that ICP-OES analysis allowed quantification of the ionized Na, Ca, Si, P, and Nb spe-
cies released from the glass, but the results do not provide any information on their bioavailability or molecular 
Time Groups Liver (g) Kidneys (g) Body Weight (g)
14 days
Control 11.4 ± 0.2 5.17 ± 0.07 366.0
BG45S5 11.4 ± 0.2 5.28 ± 0.06 381.0
BGPN1.3 11.4 ± 0.1 5.10 ± 0.09 376.0
BGPN2.6 11.2 ± 0.1 5.22 ± 0.07 373.0
Sham 11. 5 ± 0.2 5.29 ± 0.08 387.0
28 days
Control 10.8 ± 0.1 5.0 ± 0.1 474.0
BG45S5 10.8 ± 0.2 5.00 ± 0.07 466.0
BGPN1.3 10.74 ± 0.08 4.99 ± 0.05 434.0
BGPN2.6 10.9 ± 0.1 5.05 ± 0.07 421.0
Sham 10.6 ± 0.2 5.02 ± 0.04 443.0
Table 3. Relative weight of liver and kidneys of rats treated with different bioactive glasses for 14 and 28 days.
www.nature.com/scientificreports/
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structure. The dissolution products generated are likely to be in the form of compounds of the elemental constit-
uents of the glass rather than individual ions. Thus, drawing conclusions based only on ion concentration may 
seem an oversimplification. Obviously, in more complex media, such as culture media or corporeal fluid, the pres-
ence of chelating molecules and the ionic strength of the medium may alter the release profile and bioavailability 
of these species. In order to determine the levels of each element and its bioavailability, the quantification of the 
leached species from the vitreous matrix, concomitant with molecular speciation studies in a complex, more real-
istic, media, would be an ideal study, but is a technically challenging experiment. Further studies should focus on 
determining specifically which compounds are released, which intracellular pathways take part in the osteogenic 
process, and which genes are regulated by the presence of the bioglass-derived compounds.
Bone formation stimulated by Nb-containing bioactive glass. In vivo experiments were performed in 
order to analyse the bioactive properties of osteostimulation and osteoconductivity of different Nb-containing glass 
compositions. Glass rods were implanted into the tibia in rats to test their biological properties by quantifying the 
newly formed subperiosteal bone and the thickness of the bone layer formed over and near the surface of the rod.
Comparison of subperiosteal bone area in the rod group tibia and those in a control group showed no signifi-
cant difference after 14 days of implantation [F (3, 16) = 1.881, p = 0.174)] (Figs 6 and 7).
However, after 28 days, BGPN1.3 induced a significant effect on bone formation [F (3, 16) = 6.375, p = 0.005]. 
The tibia bones in which BGPN1.3 was implanted showed greater subperiostal bone area (51513.88 ± 2050.08 µ2) 
than the control (BG45S5) (46537.19 ± 2050.08 µ2) (Figs 7 and 8).
Moreover, the presence of niobium did not alter the osteoconductivity of the glass, stimulating the formation of 
a bone layer over its surface, displaying thicknesses similar to the control group [F (3,16) = 0.423, p = 0.739] (Fig. 9).
We believe the greater bone formation stimulated by Nb-containing glass was caused by the release of Nb 
species that could have acted in two ways: (a) directly acting over cells by the mechanism explained by the mech-
anism explained previously in the in vitro section of this work and (b) by acting as nucleation agent, forming 
microscopic needle-shaped crystals on the surface of the glass52. This confers a microscopic complexity to the 
glass surface, which is thought to be critical for in vivo contact osteogenesis to occur24. It is stated that a micro or 
nanoscopic complexity allows greater protein, mainly fibrin, adsorption, and that platelets aggregate on this fibrin 
net and secrete cytokines that recruit osteogenic cells to the implant site53. These cells differentiate in osteoblasts 
and produce a collagen-rich matrix which is further calcified, and newly formed bone is strongly anchored to the 
surface of the material with an interfacial bond strength equal to or greater than the natural bone7. This mecha-
nism explains the osteoconductivity displayed by all glass evaluated in the present study.
We believe that the greater subperiosteal bone formation of the different Nb glass formulations was caused 
by a direct effect of the leached ionic products (Si, Ca, Na, and P) on the periosteal osteogenic cells, possibly 
Figure 5. Micro and macrographs of calcium deposits within and around hESCs stained with alizarin red (1%)
after 21 days of treatment with different media. The four large squares show micrographs (100x magnification) 
in which the red aggregates (indicated by the arrows) are calcium deposits. The small squares show the 
photographs taken of each well. Cells treated with osteogenic medium (OS) showed a fully mineralized matrix 
which means that most hESCs were in a late stage of differentiation to osteoblasts. Those cells treated with 
BGPN1.3 showed a greater degree of matrix mineralization than those treated either with BG45S5 or DMEM/
F12. This study was carried out only for the BG45S5 and BGPN1.3 samples.
www.nature.com/scientificreports/
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throughout the mechanisms previously discussed in the section “Osteogenic potential of Nb-containing bioglass” 
of this paper. In short, the leached ionic products may ultimately have caused the upregulation of the expression 
of important genes for cellular differentiation and maturation. For example, extracellular calcium ions are known 
to increase the upregulation of IGF-II, one of the main growth factors for bone formation50,51.
Conclusion
To summarise, our results showed that the addition of Nb2O5, replacing P2O5, within glass networks increased 
bioactivity of the glass. All glass compositions derived from Bioglass® tested in the present study exhibited similar 
release profile for Si, Na and Ca species compared to BG45S5, in addition to the release of niobium species by the 
compositions of Nb-containing glass. The release of niobium species may have been responsible for the observed 
enhanced osteogenic and osteostimulative properties.
Figure 6. Micrographs of transversal histological sections of rat tibia tissues stained with Haematoxylin & 
Eosin after 14 days of implantation with different glass compositions. All groups showed similar amount of 
subperiosteal bone formation [F(3,16) = 1,881, p = 0,174, ω = 0,34].
www.nature.com/scientificreports/
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Solid state 31P MAS NMR proved to be a very sensitive technique to elucidate the in vitro chemical reactivity 
and bioactivity of niobium bioactive glass. 31P MAS NMR showed that glass containing lower quantities of Nb2O5 
(BGPN1.3) exhibited enhanced early glass apatite formation, whereas for glass compositions containing higher 
amount of Nb2O5 (BGPN2.6) the opposite effect was observed.
Nb-substituted silicate glass is not toxic to hESCs and does not cause any problems for liver and kidneys of 
rats, proving their biocompatibility. The results suggested that hESCs differentiated toward osteoblast lineage 
after treatment with the dissolution products of Nb-containing glass, revealing the osteogenic capacity of nio-
bium. In vivo experiments showed that after 28 days, Nb-containing bioglass induced a significant effect on bone 
formation.
Based upon these results, we suggest Nb-substituted silicate glass may be an interesting alternative for bio-
medical applications.
Materials and Methods
Preparation of bioglass samples. Details on the preparation of bioglass samples can be found in our 
previous publications9,29,31,32. High purity SiO2, Na2CO3, CaCO3, P2O5 powders (>99.9%), were weighed to 
obtain the glass compositions depicted in Table 1. All precursor reagents were purchased from Sigma-Aldrich (St. 
Louis, MO, USA), except for niobium oxide (Nb2O5, optical grade, >99.5%), which was donated by the CBMM 
(Companhia Brasileira de Metaluria e Mineração, Araxá, Minas Gerais, Brazil). Thirty-gram batches were melted 
in a platinum crucible at 1400 °C in air for 3 hours using a furnace (Lindberg/Blue M 1700 °C, Thermo Electron 
Corporation, Asheville, NC, USA). At the end of the refining process, the melts were quenched directly into cold 
water (frit cast), collected in a sieve, and dried to constant weight at 120 °C overnight. The different types of glass 
were then ground using an agate mortar and pestle, and sieved to separate fine (<38 µm) and coarse (>53 µm) 
particles. All experiments described in this work were carried out using glass particles size between 38–53 µm, 
excepting the in vivo studies for which cylindrical rods with 4 mm length × 2 mm diameter were used. These 
samples were prepared by casting method in a graphite mould (Fig. SI2). Glass rods were annealed at 50 °C below 
the glass transition temperature (Tg) for 12 h and slowly cooled to room temperature to release the thermal stress 
associated with the quenching process.
Ion leaching experiments by ICP-OES. The ionic leaching patterns of the bioactive glass were deter-
mined by inductively coupled plasma optical emission spectrometry (ICP-OES). In this experiment, 300 mg of 
bioglass particles were dispersed in a beaker with 200 mL of buffer solution and maintained under continuous 
stirring (stirring rate of 75 rpm), at room temperature. The solution was buffered at pH 7.40 by using 50.69 mM 
HEPES (2-(4-(2-hydroxyethyl)piperazin-1-yl)ethanesulfonic acid) and 1 mM NaOH, both purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Prior to the addition of the glass particles, 50.69 mM HEPES solution was 
passed through a 0.22 μm Millipore® filter to remove eventual aggregates or contaminants. During the leach-
ing experiment, the beaker was kept sealed with parafilm in order to avoid any loss of liquid by evaporation, 
preventing changes in the ratio of glass/HEPES in the solution. After 3, 6, 12, 24 and 48 hours, 10 mL of solu-
tion was removed with a syringe. Since the powder suspension was well dispersed and homogenous, the sample 
removal did not alter the solution concentration. For this reason, the solution was not refilled after collecting 
samples, resulting in a final volume of the solution of 150 mL. After each removal, the solution was immediately 
filtered with 0, 22 µm Millipore® filters and analysed with an ICP-OES spectrometer (Optima 8300 ICP-OES, 
PerkinElmer, Inc., Shelton, CT, USA). The calibration curves were obtained from standard solutions containing 
Ca, Na, P, Si, and Nb. In order to ensure the accuracy of the calibration curve, the standard sample concentrations 
were measured periodically. Three replicates were measured for each element. The results obtained for the same 
element from different emission lines were averaged. Each point of the graphs shown is the result of the average 
of three dissolution experiments. Elemental concentration was reported in ppm.
Figure 7. Quantitative analysis of the area of newly-formed subperiosteal bone in rats treated with the different 
bioactive glass. After 28 days the group treated with BGPN1.3 showed significantly greater bone formation 
than the control group (treated with BG45S5). All data are displayed as mean and SEM. For all comparisons 
p < 0.005 was considered.
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Formation rate of calcium phosphate layer determined by 31P MAS NMR Spectroscopy. The 
rate of formation of the calcium phosphate layer on bioglass surfaces was monitored by 31P MAS NMR. Samples 
were prepared by adding 50 mg of bioactive glass particles to 5 mL of simulated body fluid (SBF)54 (see supple-
mentary information – Table SI1), and stirring in a thermostatic bath at 37 °C. After 3, 12, 24 and 48 hours the 
solution was filtered and the remaining powder was immediately dried between two filter papers. Soon after the 
drying procedure the material was packaged in the rotor and analysed by 31P MAS NMR.
Figure 8. Micrographs of transversal histological sections of rat tibia tissues stained with Haematoxylin & 
Eosin after 28 days of implantation of different glass compositions. The groups differed regarding newly-
formed bone area [F(3,16) = 6,375,p = 0,005, ω = 0,67]. The group BGPN1.3 showed greater bone area 
(51513,88 ± 1265,13 μ2) than BG45S5 (46537,19 ± 2050,08 μ2) (p = 0.011) and BGSN1(40614,49 ± 3360,57 μ2) 
(p = 0.004) as can be seen on the micrographs in the right column (200x magnification).
www.nature.com/scientificreports/
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31P MAS NMR study was carried out using an FT-NMR (AVANCE II + 400, 9.04 T, Bruker, Rheinstetten/
Karlsruhe, Germany) at the resonance frequency 161.98 MHz, using standard Bruker double-resonance 
magic-angle sample spinning (MAS) probes. The glass particles were packed into a 4-mm cylindrical zirconia 
rotor and spun at the MAS frequency at the magic angle to remove any anisotropy effects. The samples were spun 
at 10 kHz at the ambient probe temperature. The 31P MAS spectra were obtained using a high-power decoupling 
(HPDEC) pulse sequence with 2.50 μs pulses, 82 ms acquisitions, 5 s recycle delays, a 100 kHz spectral width, and 
1024 scans. The 31P chemical shifts were referenced to 85% H3PO4. The spectra were processed with TopSpin 2.1.6 
software using Fourier transforms and an exponential filter of 50 Hz. The phase was manually adjusted, and the 
baseline was obtained using a five-order polynomial function.
Culture of human embryonic stem cells (hESCs). Human Embryonic Stem Cells (hES cells) CCTL12 
were cultured in complete human embryonic stem cell medium (cHES) composed of Dulbecco’s Modified Eagle 
Medium Nutrient Mixture F-12 (DMEM/F-12) supplemented with 2 mM of L-glutamine (Gibco®, Thermo Fisher 
Scientific Inc.) and 10 ng/mL of fibroblast growth factor 2 (FGF2, PepTech Corporation, Bedford, MA, USA). 
Before being used with hES cells, cHES was conditioned by incubation for 24 h with confluent cultures of mouse 
embryonic fibroblasts.
For all cell experiments the hES cells were cultured in flasks previously coated with BD Matrigel™ and using 
one of the following four culture media: (a) cHES; (b) Osteogenic Medium (OS), composed by cHES supplemented 
with 3 mM β-glycerolphosphate, 0.1 mM ascorbic acid and 10−8 M dexamethasone (Sigma-Aldrich, St. Louis, 
MO, USA); (c) BG45S5 medium, in which BG45S5 powder was mixed with cHES medium at 10 mg/mL; and 
(d) BGPN1.3 medium, in which Nb-substituted bioglass was mixed with cHES at a concentration of 10 mg/mL. 
All glass-conditioned media were sterilized using a 0.22 µm pore filter (which also removed the powder particles) 
prior treating the cells. Cells were incubated at 37 °C in a humid 5% CO2 atmosphere.
Cell viability – resazurin assay. Cell viability was determined by means of resazurin assay (Sigma-Aldrich, 
St. Louis, MO, USA). The culture medium was supplemented with 5 µM of resazurin and the cells were incubated 
at 37 °C and 5% CO2 for 4–6 hours. The total metabolic activity was measured by scanning the cell plate at a plate 
reader (Synergy HT, BioTek® Instruments, Inc, Winooski, VT, USA) on the fluorometry mode with excitation 
filters centred at wavelengths of 540 nm and 590 nm.
Matrix mineralization. The Alizarin red stains intracellular calcium deposits and calcium bound to proteins 
and proteoglycans55,56. This dye was used to analyse the deposition of mineralized matrix by osteoblasts, which is 
a marker of cell maturation. The test was conducted after 21 days of cell culture (the time required for observing 
matrix mineralization) within the four different experimental media. For the test, the cell monolayers were fixed 
with 70% ethanol for 1 hour at 4 °C and incubated in 1% Alizarin Red (Sigma-Aldrich, St. Louis, MO, USA) for 
10 minutes. After this period five washes in distilled water were carried out and microphotographs at 100x mag-
nification were taken from each well. Each treatment was applied to five wells per plate and the whole assay was 
performed in duplicate.
In Vivo assessment. In order to test the biological response incited by the bioactive glass, glass rods were 
implanted into rat tibia. For this, Brazilian College of Animal Experimentation (BCAE) guidelines were followed, 
and experiments were approved by Committee for Ethics in Animal Use of the University of Campinas - CEUA/
Unicamp (Protocol n° 2777–1). Rods composed of different types of glass (BGPN1.3, BGPN2.6, and BG45S5) 
were implanted into a round defect created in the tibia of rats that had been anesthetized with a mixture of 
ketamine (ANASEDAN®) at 80 mg/kg and xylazine (DOPALEN®) at 10 mg/kg. Five rats were used per group. 
Figure 9. Average thickness of newly-formed bone layer on the surface of different compositions of glass 
implants after 28 days post-surgery. All values are expressed in mean and SEM and represent thickness in 
micrometres (µm). There was no significant difference between groups [F(3,16) = 0.423, p = 0.739, ω = 0.31] 
showing they were both osteoconductive.
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After pulling aside the periosteum a round transcortical defect was created using a spherical threfine bur (JET®) 
with a diameter of 2 mm. The glass rod (4 mm length × 2 mm diameter) was carefully introduced into the defect 
until total coupling, then the periosteum and the skin were sutured. After 14 or 28 days, the animals were euth-
anized, and the tibia was obtained from the animals and fixed for 24 h at 4 °C in 10% zinc-buffered formalin 
(Sigma-Aldrich®). After fixation, they were decalcified in 5% EDTA (Synth Labsynth, Diadema, SP, Brazil), the 
glass rod was then carefully removed and the bones were paraffin-embedded and sectioned.
Systemic toxicity. To assess the systemic toxicity of the glass implants we calculated the relative weights of 
rats’ liver and kidneys. For this, immediately after euthanasia (14 or 28 days after implantation), liver and kidneys 
were dissected from the five rats of each group and weighed with a high precision scale (Unibloc®). The organ 
relative weights were calculated as the ratio between organ weight and body weight.
Morphometry. All histological sections were stained with haematoxylin and eosin dyes. A light microscope 
(80i) with a camera (DS-Ri1) and software (NIS-Elements software Advanced Research 3.0), all made by Nikon 
Corporation, Tokyo, Japan, were used to quantify the following parameters:
 i) Area of newly-formed subperiostal bone. The area of the newly-formed subperiostal bone was measured 
at one field of each side of the cortical defect, directly underneath the periosteum and adjacent to where 
the glass rod was previously located, at 400x magnification. Five non-consecutive histological sections were 
analysed per animal. Five rats were used per group (n = 5 per group). Thus, the mean and standard error of 
the mean were registered and further compared (Fig. SI3).
 ii) Thickness of newly-formed bone layer. Along the bone layer that formed around the implant we per-
formed 20 measurements of thickness. All measurements were performed at 400x magnification. Five 
rats were used per group (n = 5 per group). The mean and standard error of the mean were registered and 
further compared (Fig. SI4).
Statistical analysis. We used One-way ANOVA followed by Student Newman-Keuls test to compare the 
organ relative weights. Comparisons between means of subperiostal newly-formed bone and thickness of the 
bone layer formed around the implant were made using ANOVA one-way test with Tukey (homogeneous var-
iances) or Games-Howell (non-homogeneous variances) post-hoc. For comparisons between the amounts of 
trabecular bone formed at 14 post-operative days, a Kruskal-Wallis test was used due to the non-normality of the 
data, matching the control group with each of the other groups through Mann-Whitney tests post hoc. For all 
tests α = 0.05 was assumed. All data are presented as means and standard errors.
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